cilostazol has been researched along with Hyperinsulinism in 1 studies
Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated association between hyperinsulinemia/insulin resistance and microalbuminuria in the insulin-resistant Otsuka Long-Evans Tokushima Fatty (OLETF) rat." | 5.32 | Cilostazol, a phosphodiesterase inhibitor, reduces microalbuminuria in the insulin-resistant Otsuka Long-Evans Tokushima Fatty rat. ( Oshiro, Y; Shimabukuro, M; Shimajiri, Y; Takasu, N; Tohma, T; Yamakawa, M, 2004) |
| "We evaluated association between hyperinsulinemia/insulin resistance and microalbuminuria in the insulin-resistant Otsuka Long-Evans Tokushima Fatty (OLETF) rat." | 1.32 | Cilostazol, a phosphodiesterase inhibitor, reduces microalbuminuria in the insulin-resistant Otsuka Long-Evans Tokushima Fatty rat. ( Oshiro, Y; Shimabukuro, M; Shimajiri, Y; Takasu, N; Tohma, T; Yamakawa, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tohma, T | 1 |
| Shimabukuro, M | 1 |
| Oshiro, Y | 1 |
| Yamakawa, M | 1 |
| Shimajiri, Y | 1 |
| Takasu, N | 1 |
1 other study available for cilostazol and Hyperinsulinism
| Article | Year |
|---|---|
Cilostazol, a phosphodiesterase inhibitor, reduces microalbuminuria in the insulin-resistant Otsuka Long-Evans Tokushima Fatty rat.
Topics: Albuminuria; Animals; Blood Glucose; Cilostazol; Collagen Type I; Diabetic Nephropathies; Fibronecti | 2004 |